Estimated reading time: 0 minutes, 36 seconds

EXACT 3Q EDGES UP

Exact, which markets the Macola, Progression and Synergy lines, saw revenue of almost $78 million, a rise by 2 percent when measured in euros for the third quarter ended September and license revenue started to show growth. The company said the latter was led by the Americas and the Netherlands.

EBIDTA, however, fell by 4 per cent to roughly $17 million, as the company increased its investment in Exact Online, which is not sold in the United States, and there was also an increase in the sale of third-party products. The company has not provided a 2010 financial outlook, but in a prepared statement, the company said its goal is to restore profitable organic revenue growth. Exact says it has also initiated programs to become more market driven.
Read 1658 times
Rate this item
(0 votes)

Visit other PMG Sites:

PMG360 is committed to protecting the privacy of the personal data we collect from our subscribers/agents/customers/exhibitors and sponsors. On May 25th, the European's GDPR policy will be enforced. Nothing is changing about your current settings or how your information is processed, however, we have made a few changes. We have updated our Privacy Policy and Cookie Policy to make it easier for you to understand what information we collect, how and why we collect it.